

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lymph vessel development (GO:0001945) | 5.24461625 |
| 2 | endothelium development (GO:0003158) | 5.08877995 |
| 3 | germ cell migration (GO:0008354) | 4.71698181 |
| 4 | establishment of integrated proviral latency (GO:0075713) | 4.46628857 |
| 5 | DNA double-strand break processing (GO:0000729) | 4.21341199 |
| 6 | establishment of viral latency (GO:0019043) | 4.05790686 |
| 7 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.97110826 |
| 8 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.97110826 |
| 9 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.95731160 |
| 10 | cellular response to fluid shear stress (GO:0071498) | 3.95489891 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 3.83338743 |
| 12 | Notch signaling involved in heart development (GO:0061314) | 3.79376974 |
| 13 | monocyte differentiation (GO:0030224) | 3.69950770 |
| 14 | response to peptidoglycan (GO:0032494) | 3.65671699 |
| 15 | microglial cell activation (GO:0001774) | 3.61642510 |
| 16 | morphogenesis of an endothelium (GO:0003159) | 3.60894884 |
| 17 | endothelial tube morphogenesis (GO:0061154) | 3.60894884 |
| 18 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.60364323 |
| 19 | histamine secretion (GO:0001821) | 3.56407339 |
| 20 | hepatocyte apoptotic process (GO:0097284) | 3.52772515 |
| 21 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.51962540 |
| 22 | membrane invagination (GO:0010324) | 3.51584801 |
| 23 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.47747174 |
| 24 | branch elongation of an epithelium (GO:0060602) | 3.44798628 |
| 25 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.44348860 |
| 26 | response to X-ray (GO:0010165) | 3.43012931 |
| 27 | negative regulation of granulocyte differentiation (GO:0030853) | 3.42889901 |
| 28 | cellular glucuronidation (GO:0052695) | 3.38371843 |
| 29 | response to fluid shear stress (GO:0034405) | 3.33421036 |
| 30 | definitive hemopoiesis (GO:0060216) | 3.32538152 |
| 31 | chromatin remodeling at centromere (GO:0031055) | 3.30007836 |
| 32 | response to laminar fluid shear stress (GO:0034616) | 3.27479770 |
| 33 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.27363327 |
| 34 | regulation of endothelial cell differentiation (GO:0045601) | 3.25838506 |
| 35 | blood vessel endothelial cell migration (GO:0043534) | 3.20970682 |
| 36 | CENP-A containing nucleosome assembly (GO:0034080) | 3.20366424 |
| 37 | macrophage activation (GO:0042116) | 3.14946330 |
| 38 | surfactant homeostasis (GO:0043129) | 3.14112985 |
| 39 | cellular extravasation (GO:0045123) | 3.13316736 |
| 40 | mitotic G2/M transition checkpoint (GO:0044818) | 3.12150809 |
| 41 | positive regulation of vasculogenesis (GO:2001214) | 3.10778565 |
| 42 | uronic acid metabolic process (GO:0006063) | 3.08958375 |
| 43 | glucuronate metabolic process (GO:0019585) | 3.08958375 |
| 44 | embryonic process involved in female pregnancy (GO:0060136) | 3.05990068 |
| 45 | negative regulation of phagocytosis (GO:0050765) | 3.05940008 |
| 46 | negative regulation of cell fate specification (GO:0009996) | 3.04963370 |
| 47 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.04295505 |
| 48 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.04295505 |
| 49 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.04295505 |
| 50 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.04295505 |
| 51 | negative regulation of sister chromatid segregation (GO:0033046) | 3.04295505 |
| 52 | patterning of blood vessels (GO:0001569) | 3.03052712 |
| 53 | angiogenesis involved in wound healing (GO:0060055) | 3.01607511 |
| 54 | regulation of chemokine secretion (GO:0090196) | 3.01420079 |
| 55 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.00897346 |
| 56 | regulation of vasculogenesis (GO:2001212) | 2.98955919 |
| 57 | outer ear morphogenesis (GO:0042473) | 2.98927409 |
| 58 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.98514901 |
| 59 | positive regulation by symbiont of host defense response (GO:0052509) | 2.98228512 |
| 60 | modulation by symbiont of host defense response (GO:0052031) | 2.98228512 |
| 61 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.98228512 |
| 62 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.98228512 |
| 63 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.98228512 |
| 64 | modulation by symbiont of host immune response (GO:0052553) | 2.98228512 |
| 65 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.98048170 |
| 66 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.95041690 |
| 67 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.94497638 |
| 68 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.94497638 |
| 69 | negative regulation of DNA recombination (GO:0045910) | 2.92271304 |
| 70 | regulation of mononuclear cell migration (GO:0071675) | 2.90547900 |
| 71 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.90107051 |
| 72 | protein deneddylation (GO:0000338) | 2.89718791 |
| 73 | DNA replication-independent nucleosome organization (GO:0034724) | 2.88837549 |
| 74 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.88837549 |
| 75 | IMP biosynthetic process (GO:0006188) | 2.88631457 |
| 76 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.88463961 |
| 77 | cell adhesion mediated by integrin (GO:0033627) | 2.88402538 |
| 78 | lymphangiogenesis (GO:0001946) | 2.87969782 |
| 79 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.87945227 |
| 80 | regulation of mesoderm development (GO:2000380) | 2.87116205 |
| 81 | endothelial cell morphogenesis (GO:0001886) | 2.87023896 |
| 82 | negative regulation of chromosome segregation (GO:0051985) | 2.86684337 |
| 83 | endoderm formation (GO:0001706) | 2.86558408 |
| 84 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.85639199 |
| 85 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.85618098 |
| 86 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.81968130 |
| 87 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.81968130 |
| 88 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.81968130 |
| 89 | sialylation (GO:0097503) | 2.81568675 |
| 90 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.80633569 |
| 91 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.80308217 |
| 92 | histone exchange (GO:0043486) | 2.77978645 |
| 93 | mammary gland epithelial cell proliferation (GO:0033598) | 2.77929099 |
| 94 | platelet dense granule organization (GO:0060155) | 2.76814620 |
| 95 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.76253204 |
| 96 | glycosphingolipid biosynthetic process (GO:0006688) | 2.75990544 |
| 97 | phagocytosis, engulfment (GO:0006911) | 2.74578926 |
| 98 | purine nucleobase biosynthetic process (GO:0009113) | 2.71959408 |
| 99 | cullin deneddylation (GO:0010388) | 2.70821210 |
| 100 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.70819967 |
| 101 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.70760563 |
| 102 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.70270438 |
| 103 | regulation of cardioblast proliferation (GO:0003264) | 2.70270438 |
| 104 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.70053266 |
| 105 | mitotic spindle checkpoint (GO:0071174) | 2.69209581 |
| 106 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.69165473 |
| 107 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.69165473 |
| 108 | regulation of sister chromatid segregation (GO:0033045) | 2.69165473 |
| 109 | germinal center formation (GO:0002467) | 2.69090322 |
| 110 | detection of molecule of bacterial origin (GO:0032490) | 2.67742757 |
| 111 | bone remodeling (GO:0046849) | 2.66537061 |
| 112 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.66414763 |
| 113 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.65808699 |
| 114 | macrophage differentiation (GO:0030225) | 2.65785515 |
| 115 | negative regulation of interleukin-1 production (GO:0032692) | 2.65335243 |
| 116 | spindle checkpoint (GO:0031577) | 2.65240480 |
| 117 | DNA ligation (GO:0006266) | 2.64578386 |
| 118 | axon extension involved in axon guidance (GO:0048846) | 2.64272478 |
| 119 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.64272478 |
| 120 | substrate-dependent cell migration (GO:0006929) | 2.63266458 |
| 121 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.62599038 |
| 122 | heart field specification (GO:0003128) | 2.61869281 |
| 123 | secondary heart field specification (GO:0003139) | 2.61869281 |
| 124 | chemical homeostasis within a tissue (GO:0048875) | 2.61686875 |
| 125 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.60596625 |
| 126 | detection of other organism (GO:0098543) | 2.59531056 |
| 127 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.58847934 |
| 128 | hemidesmosome assembly (GO:0031581) | 2.58010536 |
| 129 | endothelial cell differentiation (GO:0045446) | 2.57690796 |
| 130 | IMP metabolic process (GO:0046040) | 2.57348502 |
| 131 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.57235004 |
| 132 | neutrophil mediated immunity (GO:0002446) | 2.57123581 |
| 133 | neutrophil activation (GO:0042119) | 2.56939607 |
| 134 | negative regulation of protein autophosphorylation (GO:0031953) | 2.56684899 |
| 135 | heart valve morphogenesis (GO:0003179) | 2.56360757 |
| 136 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.56270749 |
| 137 | * regulation of gastrulation (GO:0010470) | 2.54521267 |
| 138 | histamine transport (GO:0051608) | 2.53991350 |
| 139 | axis elongation (GO:0003401) | 2.53758619 |
| 140 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.53172291 |
| 141 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.52684142 |
| 142 | mesodermal cell differentiation (GO:0048333) | 2.52428095 |
| 143 | positive regulation of chemokine secretion (GO:0090197) | 2.51761842 |
| 144 | mitotic spindle assembly checkpoint (GO:0007094) | 2.51305829 |
| 145 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.51232351 |
| 146 | positive regulation of interferon-beta production (GO:0032728) | 2.51191516 |
| 147 | facial nerve structural organization (GO:0021612) | 2.51175890 |
| 148 | cartilage morphogenesis (GO:0060536) | 2.50506820 |
| 149 | response to folic acid (GO:0051593) | 2.49931419 |
| 150 | response to xenobiotic stimulus (GO:0009410) | 2.48989733 |
| 151 | response to muramyl dipeptide (GO:0032495) | 2.48533027 |
| 152 | vasculogenesis (GO:0001570) | 2.48458156 |
| 153 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.47171126 |
| 154 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.47171126 |
| 155 | lung lobe morphogenesis (GO:0060463) | 2.47111058 |
| 156 | cell proliferation involved in kidney development (GO:0072111) | 2.46266083 |
| 157 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.45707226 |
| 158 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.45707226 |
| 159 | positive regulation of male gonad development (GO:2000020) | 2.45679593 |
| 160 | sprouting angiogenesis (GO:0002040) | 2.45325451 |
| 161 | blood vessel remodeling (GO:0001974) | 2.44947578 |
| 162 | blood vessel maturation (GO:0001955) | 2.44333824 |
| 163 | regulation of helicase activity (GO:0051095) | 2.44231734 |
| 164 | Notch receptor processing (GO:0007220) | 2.43977706 |
| 165 | spindle assembly checkpoint (GO:0071173) | 2.43856236 |
| 166 | protein localization to kinetochore (GO:0034501) | 2.43419260 |
| 167 | dendritic cell migration (GO:0036336) | 2.43178742 |
| 168 | neutrophil chemotaxis (GO:0030593) | 2.42431955 |
| 169 | osteoclast differentiation (GO:0030316) | 2.42360374 |
| 170 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.41856329 |
| 171 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.41706610 |
| 172 | renal filtration (GO:0097205) | 2.41655216 |
| 173 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.41271572 |
| 174 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.41166281 |
| 175 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.40877205 |
| 176 | negative regulation of meiosis (GO:0045835) | 2.39827616 |
| 177 | response to vitamin E (GO:0033197) | 2.39734297 |
| 178 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.39684251 |
| 179 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.39330304 |
| 180 | granulocyte activation (GO:0036230) | 2.39186006 |
| 181 | macrophage activation involved in immune response (GO:0002281) | 2.38878087 |
| 182 | positive regulation of myoblast differentiation (GO:0045663) | 2.38494147 |
| 183 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.37923204 |
| 184 | negative regulation of mitosis (GO:0045839) | 2.37862453 |
| 185 | organ formation (GO:0048645) | 2.37612024 |
| 186 | metaphase plate congression (GO:0051310) | 2.37418876 |
| 187 | response to increased oxygen levels (GO:0036296) | 2.36977444 |
| 188 | response to hyperoxia (GO:0055093) | 2.36977444 |
| 189 | trabecula morphogenesis (GO:0061383) | 2.36828983 |
| 190 | basement membrane organization (GO:0071711) | 2.36589631 |
| 191 | face development (GO:0060324) | 2.36237015 |
| 192 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 2.35062744 |
| 193 | positive regulation of protein homodimerization activity (GO:0090073) | 2.35008225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.96821039 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.57790262 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.79750179 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.22280566 |
| 5 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.09038645 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.91064846 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.86153073 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.92872227 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.80226136 |
| 10 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.79462312 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.76840736 |
| 12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.66691220 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.63712147 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.61236935 |
| 15 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.53810235 |
| 16 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.53564010 |
| 17 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.39665820 |
| 18 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.37833963 |
| 19 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.37746141 |
| 20 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.33401291 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.30866234 |
| 22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.30131214 |
| 23 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.26087930 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.22011802 |
| 25 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19086685 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.14088041 |
| 27 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.11454055 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.04714409 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03762844 |
| 30 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.01564768 |
| 31 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.97683408 |
| 32 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.96644683 |
| 33 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.95094540 |
| 34 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.87715541 |
| 35 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.87715541 |
| 36 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.85690240 |
| 37 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.84341884 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.82729025 |
| 39 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.77614367 |
| 40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.77494934 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75930706 |
| 42 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74693465 |
| 43 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.72734617 |
| 44 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.71037260 |
| 45 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.70494719 |
| 46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.68522676 |
| 47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.67885539 |
| 48 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.65925986 |
| 49 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.65672436 |
| 50 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.65376562 |
| 51 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.64545166 |
| 52 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64352439 |
| 53 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.63292415 |
| 54 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.63119968 |
| 55 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62516674 |
| 56 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.60026466 |
| 57 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.60026466 |
| 58 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.60026466 |
| 59 | * POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.56630458 |
| 60 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.55835859 |
| 61 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.54303037 |
| 62 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.53007039 |
| 63 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52193147 |
| 64 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.51621214 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.50922730 |
| 66 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.48483008 |
| 67 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.47249799 |
| 68 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45970540 |
| 69 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.44720774 |
| 70 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44510879 |
| 71 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.44013225 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.42753810 |
| 73 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.42650585 |
| 74 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42236725 |
| 75 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.39777638 |
| 76 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.39229864 |
| 77 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.38671180 |
| 78 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32269493 |
| 79 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.31392883 |
| 80 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.31335153 |
| 81 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31074264 |
| 82 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.30468192 |
| 83 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.30153606 |
| 84 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.29156342 |
| 85 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.27875650 |
| 86 | CJUN_26792858_Chip-Seq_BT549_Human | 1.26979284 |
| 87 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.26256364 |
| 88 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.25976422 |
| 89 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25460582 |
| 90 | EWS_26573619_Chip-Seq_HEK293_Human | 1.25371999 |
| 91 | MYC_22102868_ChIP-Seq_BL_Human | 1.24079438 |
| 92 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.23583207 |
| 93 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23062094 |
| 94 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22980553 |
| 95 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.22014605 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20822869 |
| 97 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20424922 |
| 98 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.19508682 |
| 99 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.18561747 |
| 100 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.18352420 |
| 101 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.17293786 |
| 102 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17261903 |
| 103 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.17237125 |
| 104 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.16876965 |
| 105 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.16587861 |
| 106 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16233647 |
| 107 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.15055090 |
| 108 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.14318843 |
| 109 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12553632 |
| 110 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12018120 |
| 111 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.11834547 |
| 112 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.10673057 |
| 113 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10544649 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10310709 |
| 115 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09305784 |
| 116 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09102176 |
| 117 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08601388 |
| 118 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08565876 |
| 119 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08071786 |
| 120 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.05362679 |
| 121 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04516969 |
| 122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.02894154 |
| 123 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02659007 |
| 124 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02627281 |
| 125 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02354355 |
| 126 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.01702413 |
| 127 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01620423 |
| 128 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01617651 |
| 129 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01551755 |
| 130 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00461425 |
| 131 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00016011 |
| 132 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.99670511 |
| 133 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.99466690 |
| 134 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.98543689 |
| 135 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97073549 |
| 136 | * MYB_26560356_Chip-Seq_TH2_Human | 0.96995711 |
| 137 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.95932477 |
| 138 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.94452391 |
| 139 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93843042 |
| 140 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.93602624 |
| 141 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93192742 |
| 142 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91935498 |
| 143 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.91751287 |
| 144 | * MAF_26560356_Chip-Seq_TH1_Human | 0.90862129 |
| 145 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90826570 |
| 146 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90826570 |
| 147 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.90801734 |
| 148 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90133081 |
| 149 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.89693310 |
| 150 | * IRF1_19129219_ChIP-ChIP_H3396_Human | 0.89548035 |
| 151 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.88791909 |
| 152 | * SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.87789856 |
| 153 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.86641746 |
| 154 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.85857284 |
| 155 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84317607 |
| 156 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.84051183 |
| 157 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.84034515 |
| 158 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.83688528 |
| 159 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.83459205 |
| 160 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.83385789 |
| 161 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83338980 |
| 162 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.81669450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 3.33050656 |
| 2 | MP0001879_abnormal_lymphatic_vessel | 3.05521482 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 2.95889676 |
| 4 | MP0004272_abnormal_basement_membrane | 2.73066070 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.49658870 |
| 6 | MP0006054_spinal_hemorrhage | 2.38519409 |
| 7 | MP0004883_abnormal_blood_vessel | 2.36101411 |
| 8 | MP0005167_abnormal_blood-brain_barrier | 2.34924532 |
| 9 | MP0003724_increased_susceptibility_to | 2.34162398 |
| 10 | MP0001293_anophthalmia | 2.13235697 |
| 11 | MP0001915_intracranial_hemorrhage | 2.12908350 |
| 12 | MP0004808_abnormal_hematopoietic_stem | 2.11213046 |
| 13 | MP0009278_abnormal_bone_marrow | 2.08538530 |
| 14 | MP0003279_aneurysm | 2.08427040 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.03171904 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.02972479 |
| 17 | MP0002653_abnormal_ependyma_morphology | 2.01682652 |
| 18 | MP0002254_reproductive_system_inflammat | 1.99890279 |
| 19 | MP0009379_abnormal_foot_pigmentation | 1.97957437 |
| 20 | MP0010094_abnormal_chromosome_stability | 1.91324782 |
| 21 | MP0000465_gastrointestinal_hemorrhage | 1.89347370 |
| 22 | MP0008058_abnormal_DNA_repair | 1.87681907 |
| 23 | MP0000767_abnormal_smooth_muscle | 1.87552620 |
| 24 | MP0002396_abnormal_hematopoietic_system | 1.86936429 |
| 25 | MP0002166_altered_tumor_susceptibility | 1.81528649 |
| 26 | MP0009764_decreased_sensitivity_to | 1.77323004 |
| 27 | MP0000383_abnormal_hair_follicle | 1.73943159 |
| 28 | MP0002009_preneoplasia | 1.73705042 |
| 29 | MP0003122_maternal_imprinting | 1.73091187 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.71981821 |
| 31 | MP0005171_absent_coat_pigmentation | 1.70684888 |
| 32 | MP0003943_abnormal_hepatobiliary_system | 1.68644322 |
| 33 | MP0003436_decreased_susceptibility_to | 1.68492943 |
| 34 | MP0003890_abnormal_embryonic-extraembry | 1.66768450 |
| 35 | MP0008007_abnormal_cellular_replicative | 1.64541174 |
| 36 | MP0003303_peritoneal_inflammation | 1.62713972 |
| 37 | MP0005164_abnormal_response_to | 1.58100473 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.57923706 |
| 39 | MP0003828_pulmonary_edema | 1.55027222 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.54913160 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.54913160 |
| 42 | MP0003195_calcinosis | 1.53105613 |
| 43 | MP0010678_abnormal_skin_adnexa | 1.51511848 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 1.50267257 |
| 45 | MP0003221_abnormal_cardiomyocyte_apopto | 1.49406540 |
| 46 | MP0005408_hypopigmentation | 1.45463888 |
| 47 | MP0000858_altered_metastatic_potential | 1.44226274 |
| 48 | MP0008260_abnormal_autophagy | 1.42326340 |
| 49 | MP0005623_abnormal_meninges_morphology | 1.42233629 |
| 50 | MP0008932_abnormal_embryonic_tissue | 1.42051527 |
| 51 | MP0005023_abnormal_wound_healing | 1.40780201 |
| 52 | MP0006082_CNS_inflammation | 1.40057096 |
| 53 | MP0000249_abnormal_blood_vessel | 1.39683957 |
| 54 | MP0003091_abnormal_cell_migration | 1.38439960 |
| 55 | MP0003121_genomic_imprinting | 1.38241621 |
| 56 | MP0005248_abnormal_Harderian_gland | 1.37825011 |
| 57 | MP0009053_abnormal_anal_canal | 1.37570342 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.34380734 |
| 59 | MP0002933_joint_inflammation | 1.32082804 |
| 60 | MP0002419_abnormal_innate_immunity | 1.30994278 |
| 61 | MP0002282_abnormal_trachea_morphology | 1.30622375 |
| 62 | MP0001188_hyperpigmentation | 1.28342072 |
| 63 | MP0003693_abnormal_embryo_hatching | 1.26198990 |
| 64 | MP0004133_heterotaxia | 1.24671305 |
| 65 | MP0010307_abnormal_tumor_latency | 1.23826208 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.22598228 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.22546264 |
| 68 | MP0006072_abnormal_retinal_apoptosis | 1.21652995 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.19946050 |
| 70 | MP0003077_abnormal_cell_cycle | 1.17797102 |
| 71 | MP0005025_abnormal_response_to | 1.17555791 |
| 72 | MP0009384_cardiac_valve_regurgitation | 1.15996016 |
| 73 | * MP0002925_abnormal_cardiovascular_devel | 1.12733986 |
| 74 | MP0005367_renal/urinary_system_phenotyp | 1.12471049 |
| 75 | MP0000516_abnormal_urinary_system | 1.12471049 |
| 76 | MP0002405_respiratory_system_inflammati | 1.11931161 |
| 77 | * MP0000343_altered_response_to | 1.11766881 |
| 78 | MP0000733_abnormal_muscle_development | 1.11563938 |
| 79 | MP0002006_tumorigenesis | 1.10953337 |
| 80 | MP0001324_abnormal_eye_pigmentation | 1.10519503 |
| 81 | MP0002928_abnormal_bile_duct | 1.09768254 |
| 82 | MP0008789_abnormal_olfactory_epithelium | 1.09379775 |
| 83 | MP0003075_altered_response_to | 1.07483377 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 1.06242421 |
| 85 | MP0001614_abnormal_blood_vessel | 1.06186702 |
| 86 | MP0001286_abnormal_eye_development | 1.06002044 |
| 87 | MP0001835_abnormal_antigen_presentation | 1.04984638 |
| 88 | MP0005076_abnormal_cell_differentiation | 1.02759193 |
| 89 | MP0003941_abnormal_skin_development | 1.01865702 |
| 90 | MP0002452_abnormal_antigen_presenting | 1.01593280 |
| 91 | MP0002723_abnormal_immune_serum | 1.00591809 |
| 92 | MP0001853_heart_inflammation | 1.00109263 |
| 93 | MP0001851_eye_inflammation | 0.99528455 |
| 94 | MP0005377_hearing/vestibular/ear_phenot | 0.97692912 |
| 95 | MP0003878_abnormal_ear_physiology | 0.97692912 |
| 96 | MP0010329_abnormal_lipoprotein_level | 0.97214574 |
| 97 | MP0003111_abnormal_nucleus_morphology | 0.95318043 |
| 98 | MP0002249_abnormal_larynx_morphology | 0.95259838 |
| 99 | MP0000647_abnormal_sebaceous_gland | 0.94668260 |
| 100 | MP0002877_abnormal_melanocyte_morpholog | 0.93857133 |
| 101 | MP0009785_altered_susceptibility_to | 0.93671371 |
| 102 | MP0005671_abnormal_response_to | 0.93424197 |
| 103 | MP0002102_abnormal_ear_morphology | 0.93303151 |
| 104 | MP0000372_irregular_coat_pigmentation | 0.92878436 |
| 105 | MP0008877_abnormal_DNA_methylation | 0.91891428 |
| 106 | MP0005000_abnormal_immune_tolerance | 0.91718108 |
| 107 | MP0003638_abnormal_response/metabolism_ | 0.91337126 |
| 108 | MP0002133_abnormal_respiratory_system | 0.89576955 |
| 109 | MP0005388_respiratory_system_phenotype | 0.89576955 |
| 110 | MP0005390_skeleton_phenotype | 0.89172712 |
| 111 | MP0000762_abnormal_tongue_morphology | 0.89117694 |
| 112 | * MP0005166_decreased_susceptibility_to | 0.88449923 |
| 113 | MP0009697_abnormal_copulation | 0.88342410 |
| 114 | MP0002132_abnormal_respiratory_system | 0.87978186 |
| 115 | MP0003937_abnormal_limbs/digits/tail_de | 0.87694487 |
| 116 | MP0002233_abnormal_nose_morphology | 0.87558690 |
| 117 | MP0009840_abnormal_foam_cell | 0.86759311 |
| 118 | MP0010155_abnormal_intestine_physiology | 0.85903784 |
| 119 | MP0002128_abnormal_blood_circulation | 0.84240819 |
| 120 | MP0003448_altered_tumor_morphology | 0.83222795 |
| 121 | MP0002998_abnormal_bone_remodeling | 0.82684928 |
| 122 | MP0001191_abnormal_skin_condition | 0.82191138 |
| 123 | MP0002138_abnormal_hepatobiliary_system | 0.82003036 |
| 124 | MP0005085_abnormal_gallbladder_physiolo | 0.81921322 |
| 125 | MP0010030_abnormal_orbit_morphology | 0.81769459 |
| 126 | MP0004957_abnormal_blastocyst_morpholog | 0.80629075 |
| 127 | MP0003567_abnormal_fetal_cardiomyocyte | 0.80496059 |
| 128 | MP0003942_abnormal_urinary_system | 0.80091450 |
| 129 | MP0002420_abnormal_adaptive_immunity | 0.80020941 |
| 130 | MP0009765_abnormal_xenobiotic_induced | 0.79904516 |
| 131 | MP0002148_abnormal_hypersensitivity_rea | 0.79076910 |
| 132 | MP0008057_abnormal_DNA_replication | 0.78841090 |
| 133 | MP0008873_increased_physiological_sensi | 0.78602553 |
| 134 | MP0002111_abnormal_tail_morphology | 0.78086056 |
| 135 | MP0004264_abnormal_extraembryonic_tissu | 0.77731516 |
| 136 | MP0001819_abnormal_immune_cell | 0.77682399 |
| 137 | * MP0000689_abnormal_spleen_morphology | 0.77151795 |
| 138 | MP0002086_abnormal_extraembryonic_tissu | 0.77040529 |
| 139 | MP0005253_abnormal_eye_physiology | 0.76841255 |
| 140 | MP0005165_increased_susceptibility_to | 0.75948902 |
| 141 | MP0006138_congestive_heart_failure | 0.74745556 |
| 142 | MP0001800_abnormal_humoral_immune | 0.74409205 |
| 143 | MP0005197_abnormal_uvea_morphology | 0.74403950 |
| 144 | MP0003984_embryonic_growth_retardation | 0.73459768 |
| 145 | MP0003806_abnormal_nucleotide_metabolis | 0.73158224 |
| 146 | MP0003119_abnormal_digestive_system | 0.72796673 |
| 147 | MP0001672_abnormal_embryogenesis/_devel | 0.72247400 |
| 148 | MP0005380_embryogenesis_phenotype | 0.72247400 |
| 149 | MP0002751_abnormal_autonomic_nervous | 0.72145431 |
| 150 | MP0008469_abnormal_protein_level | 0.71603635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Urethral obstruction (HP:0000796) | 5.58450454 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 4.72716518 |
| 3 | Hematochezia (HP:0002573) | 4.72472849 |
| 4 | Colon cancer (HP:0003003) | 4.48892690 |
| 5 | Glomerulonephritis (HP:0000099) | 3.88308031 |
| 6 | Vascular tortuosity (HP:0004948) | 3.70461341 |
| 7 | Arterial tortuosity (HP:0005116) | 3.66420753 |
| 8 | Subacute progressive viral hepatitis (HP:0006572) | 3.44795983 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 3.39962237 |
| 10 | Myocardial infarction (HP:0001658) | 3.33679744 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.33261000 |
| 12 | Spastic diplegia (HP:0001264) | 3.32909081 |
| 13 | Asymmetry of the thorax (HP:0001555) | 3.16132305 |
| 14 | Nephritis (HP:0000123) | 3.13278246 |
| 15 | Complement deficiency (HP:0004431) | 3.10815336 |
| 16 | Stomatitis (HP:0010280) | 3.04609288 |
| 17 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.98848958 |
| 18 | Spontaneous hematomas (HP:0007420) | 2.96685573 |
| 19 | Orchitis (HP:0100796) | 2.94579227 |
| 20 | Meckel diverticulum (HP:0002245) | 2.93558232 |
| 21 | Onycholysis (HP:0001806) | 2.91174061 |
| 22 | Esophageal varix (HP:0002040) | 2.88556735 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 2.88094719 |
| 24 | True hermaphroditism (HP:0010459) | 2.87866798 |
| 25 | Aortic aneurysm (HP:0004942) | 2.86942101 |
| 26 | Amyloidosis (HP:0011034) | 2.86878149 |
| 27 | * Breast aplasia (HP:0100783) | 2.86207313 |
| 28 | Cortical dysplasia (HP:0002539) | 2.86202792 |
| 29 | Rhabdomyosarcoma (HP:0002859) | 2.83045324 |
| 30 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.82933012 |
| 31 | Prostate neoplasm (HP:0100787) | 2.82368140 |
| 32 | Abolished electroretinogram (ERG) (HP:0000550) | 2.81454198 |
| 33 | * Aplasia/Hypoplasia of the breasts (HP:0010311) | 2.80554895 |
| 34 | Cerebral aneurysm (HP:0004944) | 2.80142732 |
| 35 | Abnormality of the ileum (HP:0001549) | 2.78162225 |
| 36 | Optic neuritis (HP:0100653) | 2.77777883 |
| 37 | Retrobulbar optic neuritis (HP:0100654) | 2.77777883 |
| 38 | Septo-optic dysplasia (HP:0100842) | 2.75605243 |
| 39 | Abnormality of complement system (HP:0005339) | 2.75073350 |
| 40 | Milia (HP:0001056) | 2.75064916 |
| 41 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73074024 |
| 42 | Abnormality of chromosome stability (HP:0003220) | 2.71768079 |
| 43 | Heterochromia iridis (HP:0001100) | 2.69673757 |
| 44 | Abnormal lung lobation (HP:0002101) | 2.65380617 |
| 45 | Hydroureter (HP:0000072) | 2.65199540 |
| 46 | Alveolar cell carcinoma (HP:0006519) | 2.63342547 |
| 47 | Stenosis of the external auditory canal (HP:0000402) | 2.62749445 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.62642483 |
| 49 | Postnatal microcephaly (HP:0005484) | 2.57717572 |
| 50 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.45768397 |
| 51 | Aplasia cutis congenita (HP:0001057) | 2.45140515 |
| 52 | Agnosia (HP:0010524) | 2.44167068 |
| 53 | Supernumerary spleens (HP:0009799) | 2.43734634 |
| 54 | Abnormality of macrophages (HP:0004311) | 2.41757212 |
| 55 | Upper motor neuron abnormality (HP:0002127) | 2.41727988 |
| 56 | Choroideremia (HP:0001139) | 2.40818040 |
| 57 | Micronodular cirrhosis (HP:0001413) | 2.39510107 |
| 58 | Epidermoid cyst (HP:0200040) | 2.38213289 |
| 59 | Bicuspid aortic valve (HP:0001647) | 2.35506060 |
| 60 | Keratoconjunctivitis sicca (HP:0001097) | 2.33128074 |
| 61 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.31498576 |
| 62 | * Erectile abnormalities (HP:0100639) | 2.30860843 |
| 63 | Hypoplastic pelvis (HP:0008839) | 2.30807815 |
| 64 | Medulloblastoma (HP:0002885) | 2.30131158 |
| 65 | Atrophic scars (HP:0001075) | 2.29313343 |
| 66 | Biliary tract neoplasm (HP:0100574) | 2.29041835 |
| 67 | Abnormality of the nasal septum (HP:0000419) | 2.28339857 |
| 68 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.26334599 |
| 69 | Esophageal atresia (HP:0002032) | 2.25256907 |
| 70 | Interstitial pulmonary disease (HP:0006530) | 2.23606862 |
| 71 | Abnormal biliary tract physiology (HP:0012439) | 2.20168954 |
| 72 | Bile duct proliferation (HP:0001408) | 2.20168954 |
| 73 | Abnormal platelet volume (HP:0011876) | 2.19161359 |
| 74 | Recurrent abscess formation (HP:0002722) | 2.18528813 |
| 75 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.18366796 |
| 76 | Keratoconjunctivitis (HP:0001096) | 2.17812533 |
| 77 | Cutaneous melanoma (HP:0012056) | 2.17676919 |
| 78 | Broad foot (HP:0001769) | 2.17292139 |
| 79 | Stomach cancer (HP:0012126) | 2.17263679 |
| 80 | Median cleft lip (HP:0000161) | 2.16726125 |
| 81 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.15587594 |
| 82 | Increased mean platelet volume (HP:0011877) | 2.15129725 |
| 83 | Leukocytosis (HP:0001974) | 2.14220803 |
| 84 | Abnormality of the preputium (HP:0100587) | 2.12693572 |
| 85 | Bifid tongue (HP:0010297) | 2.12273476 |
| 86 | Shallow orbits (HP:0000586) | 2.11736751 |
| 87 | Duodenal stenosis (HP:0100867) | 2.11330062 |
| 88 | Small intestinal stenosis (HP:0012848) | 2.11330062 |
| 89 | Syringomyelia (HP:0003396) | 2.11279034 |
| 90 | Spinal cord lesions (HP:0100561) | 2.11279034 |
| 91 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.08633086 |
| 92 | Osteomyelitis (HP:0002754) | 2.08546265 |
| 93 | Increased density of long bones (HP:0006392) | 2.08253222 |
| 94 | Uterine leiomyosarcoma (HP:0002891) | 2.06508645 |
| 95 | Leiomyosarcoma (HP:0100243) | 2.06508645 |
| 96 | Distal lower limb amyotrophy (HP:0008944) | 2.06455035 |
| 97 | Ascites (HP:0001541) | 2.05525969 |
| 98 | Embryonal renal neoplasm (HP:0011794) | 2.05446834 |
| 99 | Prolonged bleeding time (HP:0003010) | 2.05415277 |
| 100 | Bladder carcinoma (HP:0002862) | 2.03946181 |
| 101 | Bladder neoplasm (HP:0009725) | 2.03946181 |
| 102 | Thick nail (HP:0001805) | 2.02896744 |
| 103 | Abnormal platelet function (HP:0011869) | 2.02894761 |
| 104 | Impaired platelet aggregation (HP:0003540) | 2.02894761 |
| 105 | Hyperglycinemia (HP:0002154) | 2.02684380 |
| 106 | Colitis (HP:0002583) | 2.01028541 |
| 107 | Skull defect (HP:0001362) | 2.00491743 |
| 108 | Congenital, generalized hypertrichosis (HP:0004540) | 2.00012617 |
| 109 | Mitral stenosis (HP:0001718) | 1.99266354 |
| 110 | Mesangial abnormality (HP:0001966) | 1.98493523 |
| 111 | Deep venous thrombosis (HP:0002625) | 1.98480910 |
| 112 | Adactyly (HP:0009776) | 1.98230410 |
| 113 | Cellulitis (HP:0100658) | 1.95813841 |
| 114 | Disinhibition (HP:0000734) | 1.95595252 |
| 115 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.95422675 |
| 116 | Aortic dissection (HP:0002647) | 1.93390226 |
| 117 | Ureteral obstruction (HP:0006000) | 1.92488370 |
| 118 | Inflammation of the large intestine (HP:0002037) | 1.92339853 |
| 119 | Capillary hemangiomas (HP:0005306) | 1.91228386 |
| 120 | Hepatosplenomegaly (HP:0001433) | 1.91086521 |
| 121 | Anencephaly (HP:0002323) | 1.90643283 |
| 122 | Arterial thrombosis (HP:0004420) | 1.89884701 |
| 123 | Gastrointestinal carcinoma (HP:0002672) | 1.89827703 |
| 124 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.89827703 |
| 125 | Hepatocellular carcinoma (HP:0001402) | 1.88419770 |
| 126 | Ureteral stenosis (HP:0000071) | 1.87556124 |
| 127 | Striae distensae (HP:0001065) | 1.85913994 |
| 128 | Pancreatic cysts (HP:0001737) | 1.85849481 |
| 129 | Abnormality of the axillary hair (HP:0100134) | 1.85820892 |
| 130 | Abnormality of secondary sexual hair (HP:0009888) | 1.85820892 |
| 131 | Polygenic inheritance (HP:0010982) | 1.84671506 |
| 132 | Abnormality of the duodenum (HP:0002246) | 1.84165677 |
| 133 | Viral hepatitis (HP:0006562) | 1.82614389 |
| 134 | Gastrointestinal inflammation (HP:0004386) | 1.82095014 |
| 135 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.81071980 |
| 136 | Plantar hyperkeratosis (HP:0007556) | 1.81070485 |
| 137 | Uterine neoplasm (HP:0010784) | 1.79549695 |
| 138 | Facial diplegia (HP:0001349) | 1.79144472 |
| 139 | Abnormal hair whorl (HP:0010721) | 1.78181459 |
| 140 | Enlarged penis (HP:0000040) | 1.77326728 |
| 141 | Sloping forehead (HP:0000340) | 1.76194647 |
| 142 | Abnormal foot bone ossification (HP:0010675) | 1.76184779 |
| 143 | Joint hemorrhage (HP:0005261) | 1.74651309 |
| 144 | Short humerus (HP:0005792) | 1.73952827 |
| 145 | Gastrointestinal atresia (HP:0002589) | 1.73736877 |
| 146 | Long clavicles (HP:0000890) | 1.73031806 |
| 147 | Ependymoma (HP:0002888) | 1.72295607 |
| 148 | Anophthalmia (HP:0000528) | 1.72142902 |
| 149 | Thyroiditis (HP:0100646) | 1.72030555 |
| 150 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.71664822 |
| 151 | Microglossia (HP:0000171) | 1.71102210 |
| 152 | Recurrent bacterial skin infections (HP:0005406) | 1.69933726 |
| 153 | Growth hormone excess (HP:0000845) | 1.69640548 |
| 154 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.68763563 |
| 155 | Palpebral edema (HP:0100540) | 1.68645397 |
| 156 | Adrenal hypoplasia (HP:0000835) | 1.68511059 |
| 157 | Clubbing of toes (HP:0100760) | 1.68353248 |
| 158 | Lymphangioma (HP:0100764) | 1.68178683 |
| 159 | Myositis (HP:0100614) | 1.68175067 |
| 160 | Germ cell neoplasia (HP:0100728) | 1.68167192 |
| 161 | Loss of speech (HP:0002371) | 1.67219488 |
| 162 | Hypochromic microcytic anemia (HP:0004840) | 1.66707889 |
| 163 | Acute myeloid leukemia (HP:0004808) | 1.65962692 |
| 164 | Abnormality of methionine metabolism (HP:0010901) | 1.65485211 |
| 165 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.65188640 |
| 166 | Oligodontia (HP:0000677) | 1.65168410 |
| 167 | Pancreatic fibrosis (HP:0100732) | 1.64341789 |
| 168 | Submucous cleft hard palate (HP:0000176) | 1.63322370 |
| 169 | Postaxial foot polydactyly (HP:0001830) | 1.63092201 |
| 170 | Gonadotropin excess (HP:0000837) | 1.62745360 |
| 171 | Amyotrophic lateral sclerosis (HP:0007354) | 1.62625417 |
| 172 | Chronic diarrhea (HP:0002028) | 1.62609735 |
| 173 | Disproportionate tall stature (HP:0001519) | 1.61809238 |
| 174 | Abnormality of serum amino acid levels (HP:0003112) | 1.61667375 |
| 175 | Encephalitis (HP:0002383) | 1.61508649 |
| 176 | Abnormality of the anterior chamber (HP:0000593) | 1.60427455 |
| 177 | Urticaria (HP:0001025) | 1.59746806 |
| 178 | Eosinophilia (HP:0001880) | 1.59591198 |
| 179 | Ovarian neoplasm (HP:0100615) | 1.59325008 |
| 180 | Tetraparesis (HP:0002273) | 1.58128883 |
| 181 | Premature loss of primary teeth (HP:0006323) | 1.57183611 |
| 182 | Neoplasm of striated muscle (HP:0009728) | 1.56241687 |
| 183 | Periodontitis (HP:0000704) | 1.56204206 |
| 184 | Medial flaring of the eyebrow (HP:0010747) | 1.55722762 |
| 185 | Disproportionate short-trunk short stature (HP:0003521) | 1.54375402 |
| 186 | Neoplasm of the colon (HP:0100273) | 1.54104468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.59757199 |
| 2 | CASK | 4.15277545 |
| 3 | EIF2AK3 | 3.66588595 |
| 4 | KDR | 3.44605172 |
| 5 | TRIM28 | 3.17908162 |
| 6 | EPHA2 | 3.13854817 |
| 7 | FRK | 3.06378502 |
| 8 | TIE1 | 3.00659393 |
| 9 | ERBB4 | 2.91114811 |
| 10 | TNIK | 2.80129728 |
| 11 | WNK3 | 2.53243927 |
| 12 | NLK | 2.50691745 |
| 13 | PAK4 | 2.44040124 |
| 14 | SRPK1 | 2.38225797 |
| 15 | BMPR1B | 2.23960799 |
| 16 | TSSK6 | 2.23376889 |
| 17 | BRSK2 | 1.98942154 |
| 18 | MAP2K3 | 1.91779480 |
| 19 | WEE1 | 1.89829767 |
| 20 | STK10 | 1.89168906 |
| 21 | TGFBR1 | 1.85398828 |
| 22 | BUB1 | 1.82943864 |
| 23 | STK38L | 1.77042984 |
| 24 | KIT | 1.75499232 |
| 25 | CDK19 | 1.65297700 |
| 26 | FLT3 | 1.64111011 |
| 27 | ACVR1B | 1.63237794 |
| 28 | FGR | 1.63210667 |
| 29 | ERBB3 | 1.60696441 |
| 30 | MAP3K12 | 1.53685560 |
| 31 | CDC7 | 1.53612811 |
| 32 | GRK6 | 1.52255222 |
| 33 | TEC | 1.49948628 |
| 34 | AKT3 | 1.48263368 |
| 35 | MAP4K2 | 1.46462476 |
| 36 | BCR | 1.45568342 |
| 37 | MKNK2 | 1.43647821 |
| 38 | CDK6 | 1.42188465 |
| 39 | MST4 | 1.39701198 |
| 40 | MAPK15 | 1.38641009 |
| 41 | NEK1 | 1.38569049 |
| 42 | MKNK1 | 1.37994376 |
| 43 | CSF1R | 1.34400005 |
| 44 | EIF2AK2 | 1.33080883 |
| 45 | PLK4 | 1.32297234 |
| 46 | MAP3K14 | 1.24939321 |
| 47 | GRK7 | 1.23662169 |
| 48 | DYRK3 | 1.23320002 |
| 49 | PKN2 | 1.23171425 |
| 50 | TRPM7 | 1.22215837 |
| 51 | MAP3K3 | 1.21148309 |
| 52 | SGK2 | 1.19463994 |
| 53 | VRK2 | 1.16230243 |
| 54 | CLK1 | 1.15698699 |
| 55 | MAPK7 | 1.14950201 |
| 56 | FER | 1.11585589 |
| 57 | SIK3 | 1.11269980 |
| 58 | CHUK | 1.08745563 |
| 59 | RPS6KB2 | 1.07297204 |
| 60 | PIM2 | 1.05465326 |
| 61 | DAPK2 | 1.03992942 |
| 62 | BLK | 1.03951719 |
| 63 | BRD4 | 1.03749764 |
| 64 | CSK | 1.02365419 |
| 65 | FGFR3 | 1.01696581 |
| 66 | PTK2B | 1.01360589 |
| 67 | PTK6 | 1.01015942 |
| 68 | TTK | 1.00916071 |
| 69 | EPHB2 | 0.97886532 |
| 70 | CCNB1 | 0.96835682 |
| 71 | PIM1 | 0.95700079 |
| 72 | VRK1 | 0.91799305 |
| 73 | TESK2 | 0.89719864 |
| 74 | TAF1 | 0.88288224 |
| 75 | IKBKE | 0.87639227 |
| 76 | MAPK12 | 0.85334491 |
| 77 | MATK | 0.85192241 |
| 78 | PLK2 | 0.84473001 |
| 79 | PDK2 | 0.82606376 |
| 80 | CSNK1A1L | 0.82370383 |
| 81 | ZAP70 | 0.81647836 |
| 82 | PLK1 | 0.80916114 |
| 83 | NUAK1 | 0.80558598 |
| 84 | RIPK1 | 0.78447865 |
| 85 | ITK | 0.77955783 |
| 86 | PBK | 0.76128925 |
| 87 | CDK8 | 0.75957885 |
| 88 | CSNK1G3 | 0.75308284 |
| 89 | NME2 | 0.74667717 |
| 90 | MAP4K1 | 0.74236323 |
| 91 | FGFR1 | 0.73309615 |
| 92 | DAPK1 | 0.72377738 |
| 93 | BTK | 0.71812706 |
| 94 | PLK3 | 0.70257608 |
| 95 | FGFR2 | 0.69943421 |
| 96 | SGK3 | 0.69795015 |
| 97 | FGFR4 | 0.67949253 |
| 98 | BRSK1 | 0.67861137 |
| 99 | FES | 0.66172333 |
| 100 | EEF2K | 0.66135023 |
| 101 | CSNK1G2 | 0.64050952 |
| 102 | MYLK | 0.63254908 |
| 103 | IRAK4 | 0.61332607 |
| 104 | SCYL2 | 0.58768122 |
| 105 | RPS6KC1 | 0.57482278 |
| 106 | RPS6KL1 | 0.57482278 |
| 107 | NEK9 | 0.57028937 |
| 108 | TYK2 | 0.56914719 |
| 109 | DYRK1B | 0.56674779 |
| 110 | YES1 | 0.56559525 |
| 111 | GSK3A | 0.55331866 |
| 112 | RPS6KA4 | 0.54514435 |
| 113 | LRRK2 | 0.54285436 |
| 114 | CSNK1G1 | 0.53258970 |
| 115 | BMX | 0.53010083 |
| 116 | MAPK4 | 0.52277298 |
| 117 | PTK2 | 0.51880534 |
| 118 | OXSR1 | 0.51499063 |
| 119 | RPS6KA6 | 0.49027610 |
| 120 | MAP2K2 | 0.47831143 |
| 121 | IGF1R | 0.46743864 |
| 122 | MAP3K10 | 0.46129862 |
| 123 | TAOK2 | 0.46080512 |
| 124 | LIMK1 | 0.44932732 |
| 125 | LYN | 0.44796863 |
| 126 | CAMK4 | 0.44771106 |
| 127 | EPHA4 | 0.44220770 |
| 128 | TBK1 | 0.43938483 |
| 129 | MAP2K7 | 0.43561722 |
| 130 | MOS | 0.42270912 |
| 131 | MAP3K5 | 0.41469927 |
| 132 | MAPKAPK2 | 0.40590400 |
| 133 | IKBKB | 0.40042736 |
| 134 | ERN1 | 0.39599420 |
| 135 | ADRBK2 | 0.39463893 |
| 136 | LCK | 0.38971689 |
| 137 | TESK1 | 0.38184961 |
| 138 | PAK2 | 0.37632696 |
| 139 | BCKDK | 0.36198891 |
| 140 | MET | 0.36169311 |
| 141 | IRAK3 | 0.35945575 |
| 142 | ATR | 0.35631933 |
| 143 | ZAK | 0.35618357 |
| 144 | EPHB1 | 0.34704113 |
| 145 | EGFR | 0.34581631 |
| 146 | MAP3K11 | 0.34466909 |
| 147 | DYRK1A | 0.34149267 |
| 148 | PRKG2 | 0.33283314 |
| 149 | STK24 | 0.31045586 |
| 150 | ABL1 | 0.29288245 |
| 151 | CAMK1D | 0.28463611 |
| 152 | MELK | 0.27670974 |
| 153 | BMPR2 | 0.27243405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.94149717 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.91175602 |
| 3 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.90839009 |
| 4 | Adherens junction_Homo sapiens_hsa04520 | 2.68180242 |
| 5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.57409084 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.46687231 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.45332826 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.43687032 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.18563184 |
| 10 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.18362258 |
| 11 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.12338970 |
| 12 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.07545941 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.01739101 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 2.01280083 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.00755662 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.94262790 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.86693352 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.85696535 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.85327723 |
| 20 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.78225156 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.76855205 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.76006979 |
| 23 | Base excision repair_Homo sapiens_hsa03410 | 1.72968419 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.70372645 |
| 25 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.69449761 |
| 26 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.66837609 |
| 27 | DNA replication_Homo sapiens_hsa03030 | 1.65470327 |
| 28 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.59165438 |
| 29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.56886882 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.54507609 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.52815211 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.52031017 |
| 33 | Spliceosome_Homo sapiens_hsa03040 | 1.44562521 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.44375083 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.44096167 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.43987526 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43913584 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.42625273 |
| 39 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.42169827 |
| 40 | Focal adhesion_Homo sapiens_hsa04510 | 1.40724760 |
| 41 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.39379023 |
| 42 | RNA polymerase_Homo sapiens_hsa03020 | 1.38710608 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.37998243 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.36480084 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.30331346 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.30152833 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29416900 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.28707171 |
| 49 | Colorectal cancer_Homo sapiens_hsa05210 | 1.28415675 |
| 50 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.27946922 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.27856086 |
| 52 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.26580869 |
| 53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.26539451 |
| 54 | Malaria_Homo sapiens_hsa05144 | 1.24812336 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 1.24780297 |
| 56 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.23844854 |
| 57 | Prostate cancer_Homo sapiens_hsa05215 | 1.21415362 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 1.20549241 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.18281106 |
| 60 | Measles_Homo sapiens_hsa05162 | 1.16236349 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 1.15999776 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15405606 |
| 63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15339955 |
| 64 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.14901546 |
| 65 | Cell cycle_Homo sapiens_hsa04110 | 1.13703470 |
| 66 | RNA transport_Homo sapiens_hsa03013 | 1.13443144 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.12512391 |
| 68 | Bladder cancer_Homo sapiens_hsa05219 | 1.11817694 |
| 69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10604980 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09925970 |
| 71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09790132 |
| 72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.09241153 |
| 73 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.06494322 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04400583 |
| 75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.04065046 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.03938331 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03619876 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 1.03207938 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 1.03060072 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00474558 |
| 81 | Pathways in cancer_Homo sapiens_hsa05200 | 0.98824333 |
| 82 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98608995 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.98193342 |
| 84 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97855203 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96250109 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96052968 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.94877184 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92494186 |
| 89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92326239 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.92253921 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90971870 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.90636669 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.87462785 |
| 94 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.86531437 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.86333333 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86074910 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84108145 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84082701 |
| 99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82641457 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.81421289 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.81350644 |
| 102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80720248 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.79949883 |
| 104 | Basal transcription factors_Homo sapiens_hsa03022 | 0.79804202 |
| 105 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.78118182 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.78056907 |
| 107 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.77326341 |
| 108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77312071 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.76531141 |
| 110 | Melanoma_Homo sapiens_hsa05218 | 0.73650331 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72784547 |
| 112 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72194433 |
| 113 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.71654337 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.71541108 |
| 115 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.71275497 |
| 116 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70631661 |
| 117 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70048543 |
| 118 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70038712 |
| 119 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.69191468 |
| 120 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68798410 |
| 121 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68739348 |
| 122 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68065583 |
| 123 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.67333261 |
| 124 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67084517 |
| 125 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66909166 |
| 126 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66135698 |
| 127 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.64187687 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.63120803 |
| 129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62759244 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.61298130 |
| 131 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.61203786 |
| 132 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60344306 |
| 133 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59990615 |
| 134 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.58553370 |
| 135 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58329628 |
| 136 | Tight junction_Homo sapiens_hsa04530 | 0.57443863 |
| 137 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57412968 |
| 138 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56972964 |
| 139 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56563599 |
| 140 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55295297 |
| 141 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.54410526 |
| 142 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53524684 |
| 143 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53255190 |
| 144 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52065446 |
| 145 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49556312 |
| 146 | Melanogenesis_Homo sapiens_hsa04916 | 0.49323654 |
| 147 | Axon guidance_Homo sapiens_hsa04360 | 0.49211641 |
| 148 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.48694712 |
| 149 | Purine metabolism_Homo sapiens_hsa00230 | 0.48627600 |
| 150 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45324220 |
| 151 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42818890 |
| 152 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.38922977 |
| 153 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34176212 |

